<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2072-8174</journal-id>
<journal-title><![CDATA[Revista del Nacional (Itauguá)]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. Nac. (Itauguá)]]></abbrev-journal-title>
<issn>2072-8174</issn>
<publisher>
<publisher-name><![CDATA[Hospital Nacional (Itauguá)]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2072-81742018000100004</article-id>
<article-id pub-id-type="doi">10.18004/rdn2018.0010.01.004-016</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Factores de riesgo cardiovascular y síndrome metabólico en pacientes con lupus eritematoso sistémico]]></article-title>
<article-title xml:lang="en"><![CDATA[Cardiovascular Risk Factors and Metabolic Syndrome in Patients with SLE]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Montiel de Jarolin]]></surname>
<given-names><![CDATA[Dora Elizabeth]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Ministerio de Salud Pública y Bienestar Social Hospital Nacional Departamento de MedicinaInterna]]></institution>
<addr-line><![CDATA[Itauguá ]]></addr-line>
<country>Paraguay</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>06</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>06</month>
<year>2018</year>
</pub-date>
<volume>10</volume>
<numero>1</numero>
<fpage>4</fpage>
<lpage>16</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.iics.una.py/scielo.php?script=sci_arttext&amp;pid=S2072-81742018000100004&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.iics.una.py/scielo.php?script=sci_abstract&amp;pid=S2072-81742018000100004&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.iics.una.py/scielo.php?script=sci_pdf&amp;pid=S2072-81742018000100004&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN  Introducción: La aterosclerosis acelerada que ocurre en el LES se considera uno de los mecanismos fundamentales del aumento de la mortalidad de causa cardiovascular. Entre los factores que contribuyen al proceso de la aterosclerosis acelerada se incluyen factores de riesgo cardiovascular tradicionales y factores relacionados con el LES.  Objetivo: identificar los factores de riesgo cardiovasculares relacionados con el LES y los factores de riesgo tradicionales asociados en pacientes con LES.  Material ymétodo: estudiodescriptivo de corte trasverso con componente analíticode pacientes con diagnóstico de LES que acudieron al Hospital Día del Departamento de Medicina Interna del Hospital Nacional de enero 2015 a marzo 2016. Las variables analizadas fueron: edad, procedencia, sexo, tiempo de diagnóstico del LES, actividad de la enfermedad, presencia de nefritis lúpica, nefropatía crónica, sobrepeso, obesidad, cintura en cm, antecedentes de sedentarismo, tabaquismo, hipertensión arterial (HTA), HTA controlada, hipercolesterolemia, hipertigliceridemia, HDL bajo, síndrome metabólico, anticuerpoanticardiolipina. Para el componente analítico se utilizó la prueba del Chi cuadrado y regresión logística para establecer asociación entre las variables.  Resultados: fueron estudiados 114 pacientes, siendo 96 del sexo femenino (84,2%) y18 del masculino (16%). La edad media fue 36±14 años. Procedíandel Departamento Central 42(42%) e interior 59(58%). El tiempo medio de diagnóstico de LES fue 5±6años.Se halló LES activo 40(35%), nefritis lúpica 46(40,4%), sobrepeso 43(38%), obesidad 18(16%), sedentarismo 52(46%), HTA 47(42%), con HTA controlada 24(24%),tabaquismo3(3%), etilismo3(3%). Tenían hipercolesterolemia 38(33,8%), hipertrigliceridemia24(21,1%) c-HDL bajo 44(40%). La frecuencia de síndrome metabólico fue 2%. Ac anticardiolipinafue positivo en 1, C3 y C4aumentado en 5(4,4%) y nefropatía crónica 11(10%). La dosis media de prednisona fue 25mg/día. Hubo 1 infarto agudo de miocardio, elelectrocardiograma (ECG) fue anormal en 5 y ecocardiografía anormal en 14 casos. La nefritis lúpica se asociósignificativamente con el desarrollo de HTA (p 0,05).  Conclusión: los principales factores de riesgo vascular relacionados con el LES fueron:actividadde la enfermedad, tiempo de enfermedad, nefritis lúpica. Los principales factores de riesgo vascular tradicionales identificados fueron: HTA, sobrepeso/obesidad, cHDL bajo, sedentarismo, dislipidemia. La frecuencia del síndrome metabólico fue bajo (2%).La presencia de nefritis lúpica se relacionó en forma estadísticamente significativa con el desarrollo de HTA.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT  Introduction:  accelerated atherosclerosis that occurs in SLE is considered one of the principal mechanisms of increased mortality due to cardiovascular causes. Between factors which contribute to the process of accelerated atherosclerosis include traditional cardiovascular risk factors and factors related to SLE.  Objective:  to identify the cardiovascular risk factors related to SLE and the associated traditional risk factors in patients with SLE.  Material and method:  descriptive study of transverse section with analytical component of patients diagnosed with SLE who attended to Day Hospital of the Department of Internal Medicine of the National Hospital from January 2015 to March 2016. The variables analyzed were: age, origin, sex, time of diagnosis of SLE, activity of the disease, presence of lupus nephritis, chronic nephropathy, overweight, obesity, waist in cm, history of sedentary lifestyle, smoking, hypertension (HBP), controlled hypertension, hypercholesterolemia, hypertiglyceridemia, low HDL, metabolic syndrome, antibody anticardiolipin. For the analytical component, the Chi square test and logistic regression were used to establish an association between the variables.  Results:  114 patients were studied, 96 being female (84.2%) and 18 male (16%). The average age was 36 ± 14 years. They came from the Central Department 42 (42%) and inland 59 (58%). The mean time of diagnosis of SLE was 5 ± 6 years. We found active SLE in 40 (35%), lupus nephritis 46 (40.4%), overweight 43 (38%), obesity 18 (16%), sedentary lifestyle 52 (46%), HTA 47 (42%), HBP controlled 24 (24%), smoking 3 (3%), alcoholism 3 (3%). They had hypercholesterolemia 38 (33.8%), hypertriglyceridemia 24 (21.1%) c-HDL low 44 (40%). The frequency of metabolic syndrome was 2%. Ac anticardiolipin was positive in 1, C3 and C4 increased by 5 (4.4%) and nephropathy in disease 11 (10%). The average dose of prednisone was 25 mg / day. There was 1 acute myocardial infarction, elelectrocardiogram (ECG) was abnormal in 5 and abnormal echocardiography in 14 cases. Lupus nephritis was significantly associated with the development of hypertension (p 0.05).  Conclusion:  the main vascular risk factors related to SLE were: activity of the disease, time of illness, lupus nephritis. The main traditional vascular risk factors identified were: hypertension, overweight / obesity, low HDL-C, sedentary lifestyle, dyslipidemia. The frequency of the metabolic syndrome was low (2%). The presence of lupus nephritis was related in a statistically significant way with the development of hypertension.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[lupus eritematoso sistémico]]></kwd>
<kwd lng="es"><![CDATA[factores de riesgo cardiovascular]]></kwd>
<kwd lng="es"><![CDATA[síndrome metabólico.]]></kwd>
<kwd lng="en"><![CDATA[systemic lupus erythematosus]]></kwd>
<kwd lng="en"><![CDATA[cardiovascular risk factors]]></kwd>
<kwd lng="en"><![CDATA[metabolic syndrome.]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pérez Gómez A]]></surname>
<given-names><![CDATA[Ruiz Gutiérrez]]></given-names>
</name>
<name>
<surname><![CDATA[M. Sánchez A]]></surname>
<given-names><![CDATA[Quintana. C.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Lupus eritematoso sistémico (I)]]></article-title>
<source><![CDATA[Medicine]]></source>
<year>2013</year>
<volume>11</volume>
<numero>32</numero>
<issue>32</issue>
<page-range>1955-65</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rahman]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Isenberg]]></surname>
<given-names><![CDATA[DA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Systemic Lupus Erythematosus]]></article-title>
<source><![CDATA[N Engl J Med]]></source>
<year>2008</year>
<volume>358</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>929-39</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pérez]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Pérez]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Vázquez Gómez]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Factores asociados al riesgo vascular en pacientes con lupus eritematoso sistémico]]></article-title>
<source><![CDATA[Acta Médica del Centro]]></source>
<year>2013</year>
<volume>7</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>1-10</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Calderón-Ticona]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Frecuencia dedislipidemia en pacientes con lupus sistémico]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Garro García]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Calvo]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<source><![CDATA[SPMI]]></source>
<year>2002</year>
<volume>15</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>1-7</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Navarro]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Martínez]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Silva]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Pérez-Ybarra]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Ruíz]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[López]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Factores de riesgo cardiovascular en pacientes con lupus eritematososistémico]]></article-title>
<source><![CDATA[ODOUS Cientifica]]></source>
<year>2011</year>
<volume>12</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>14-20</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Villa-Forte]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Mandell]]></surname>
<given-names><![CDATA[BF]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Trastornos cardiovasculares y enfermedad reumática]]></article-title>
<source><![CDATA[Rev Esp Cardiol]]></source>
<year>2011</year>
<volume>64</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>809-17</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Magro-Checa]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Salvatierra]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Rosales]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Raya Álvarez]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Riesgo cardiovascular en el lupus eritematoso sistémico factores implicados y métodos para su valoración]]></article-title>
<source><![CDATA[Semin Fund Esp Reumatol]]></source>
<year>2012</year>
<volume>13</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>95-102</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ross]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Atherosclerosis-an inflammatory disease]]></article-title>
<source><![CDATA[N Engl J Med]]></source>
<year>1999</year>
<volume>340</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>115-26</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chung]]></surname>
<given-names><![CDATA[CP]]></given-names>
</name>
<name>
<surname><![CDATA[Oeser]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Avalos]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Raggi]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Stein]]></surname>
<given-names><![CDATA[CM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cardiovascular risk scores and the presence of subclinical coronary artery atherosclerosis in women with systemic lupus erythematosus]]></article-title>
<source><![CDATA[Lupus]]></source>
<year>2006</year>
<volume>15</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>562-9</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Calderón-González]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[García-Fernández]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Enfermedad renal crónica clasificación, etiopatogenia y factores pronósticos]]></article-title>
<source><![CDATA[Medicine]]></source>
<year>2011</year>
<volume>10</volume>
<numero>79</numero>
<issue>79</issue>
<page-range>5364-9</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[James]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Oppari]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Carter]]></surname>
<given-names><![CDATA[BL]]></given-names>
</name>
<name>
<surname><![CDATA[Cushman]]></surname>
<given-names><![CDATA[WC]]></given-names>
</name>
<name>
<surname><![CDATA[Dennison-Himmelfarb]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Handler]]></surname>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[2014 evidence-based guideline forthe management of high blood pressure in adults report from the panel members appointed to the Eighth Joint NationalCommittee (JNC 8)]]></article-title>
<source><![CDATA[JAMA]]></source>
<year>2014</year>
<volume>311</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>507-20</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rodríguez]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Obesidad, concepto, clasificación, implicaciones fisiopatológicas, Complicaciones asociadas]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Mas]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Frühbeck Martínez]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<source><![CDATA[Medicine]]></source>
<year>2004</year>
<volume>9</volume>
<numero>19</numero>
<issue>19</issue>
<page-range>1167-75</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zimmet]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Alberti]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Shaw]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Nueva definición mundial de la FID del síndromemetabólico]]></article-title>
<source><![CDATA[Diabetes]]></source>
<year>2005</year>
<volume>50</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>31-3</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Calmarza Calmarzaa]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Civeira Murillob]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Protocolo diagnóstico de las dislipidemias]]></article-title>
<source><![CDATA[Medicine]]></source>
<year>2013</year>
<volume>11</volume>
<numero>40</numero>
<issue>40</issue>
<page-range>2424-8</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Roman]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
<name>
<surname><![CDATA[Shanker]]></surname>
<given-names><![CDATA[BA]]></given-names>
</name>
<name>
<surname><![CDATA[Davis]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Lockshin]]></surname>
<given-names><![CDATA[MD]]></given-names>
</name>
<name>
<surname><![CDATA[Sammaritano]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[SimantovR]]></surname>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus]]></article-title>
<source><![CDATA[N Engl J Med]]></source>
<year>2003</year>
<volume>349</volume>
<numero>25</numero>
<issue>25</issue>
<page-range>2399-406</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<collab>Expert Panel on Detection.Evaluation.and Treatment of High Blood Cholesterol in Adults</collab>
<article-title xml:lang=""><![CDATA[Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)]]></article-title>
<source><![CDATA[JAMA]]></source>
<year>2001</year>
<volume>285</volume>
<numero>24</numero>
<issue>24</issue>
<page-range>86-97</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Romero-Moreno]]></surname>
<given-names><![CDATA[JR]]></given-names>
</name>
<name>
<surname><![CDATA[Ramírez-Villafaña]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[González-Ponce]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Díaz-Rizo]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Araújo-López]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez-Hernández]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Síndrome metabólico en lupus eritematoso sistémico]]></article-title>
<source><![CDATA[El Residente]]></source>
<year>2014</year>
<volume>9</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>116-23</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Parker]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Bruce]]></surname>
<given-names><![CDATA[IN]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The metabolic syndrome in systemic lupus erythematosus]]></article-title>
<source><![CDATA[Rheum Dis Clin North Am]]></source>
<year>2010</year>
<volume>36</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>81-97</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Parker]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Urowitz]]></surname>
<given-names><![CDATA[MB]]></given-names>
</name>
<name>
<surname><![CDATA[Gladman]]></surname>
<given-names><![CDATA[DD]]></given-names>
</name>
<name>
<surname><![CDATA[Lunt]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Bae]]></surname>
<given-names><![CDATA[SC]]></given-names>
</name>
<name>
<surname><![CDATA[Sanchez-Guerrero]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Clinical associations of the metabolic syndrome in systemic lupus erythematosus data from an international inception cohort]]></article-title>
<source><![CDATA[Ann Rheum Dis]]></source>
<year>2013</year>
<volume>72</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>1308-14</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[El Magadmi]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Ahmad]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Turkie]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Yates]]></surname>
<given-names><![CDATA[AP]]></given-names>
</name>
<name>
<surname><![CDATA[Sheikh]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Bernstein]]></surname>
<given-names><![CDATA[RM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Hyperinsulinemia, insulin resis-tance, and circulcating oxidized low density lipoprotein in women with systemic lupus erythematosus]]></article-title>
<source><![CDATA[J Rheumatol]]></source>
<year>2006</year>
<volume>33</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>50-6</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Batún Garrido]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Radillo]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Hernández Núnez]]></surname>
<given-names><![CDATA[AE]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Riesgo cardiovascular en lupus eritematoso sistémico]]></article-title>
<source><![CDATA[Rev Colomb Reumatol]]></source>
<year>2016</year>
<volume>23</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>242-9</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Batún Garrido]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Radillo]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[HernándezNuñez]]></surname>
<given-names><![CDATA[AE]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Riesgo cardiovascular en lupus eritematoso sistémico]]></article-title>
<source><![CDATA[Rev Colomb Reumatol]]></source>
<year>2016</year>
<volume>23</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>242-9</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[SilvariñoR]]></surname>
</name>
<name>
<surname><![CDATA[Sato]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Factores de riesgo para aterosclerosis en enfermedades autoinmunitarias sistémicas]]></article-title>
<source><![CDATA[Rev Med Urug]]></source>
<year>2008</year>
<volume>24</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>118-32</page-range></nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Diaz Cortez]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Compromiso del sistema nervioso centralen el lupus eritematoso sistemico]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Correa Gonzalez]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Diaz]]></surname>
<given-names><![CDATA[MC]]></given-names>
</name>
<name>
<surname><![CDATA[Gutierrez]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Fernandez Avila]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<source><![CDATA[Rev Colomb Reumatol]]></source>
<year>2015</year>
<volume>22</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>16-30</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
